MetaADEDB 2.0 @ LMMD
Cetirizine
(ZKLPARSLTMPFCP-UHFFFAOYSA-N)
Structure
SMILES
OC(=O)COCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1
Type(s)
Approved
ATC code(s)
R06AE07
Molecular Formula:
C21H25ClN2O3
Molecular Weight:
388.888
Log P:
3.0240
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
1
TPSA:
53.01
CAS Number(s):
83881-51-0
Synonym(s)
1.
Cetirizine
2.
(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic Acid
3.
Alerlisin
4.
Cetalerg
5.
Ceterifug
6.
Ceti TAD
7.
Ceti-Puren
8.
CetiLich
9.
Cetiderm
10.
Cetidura
11.
Cetil von ct
12.
Cetirigamma
13.
Cetirizin AL
14.
Cetirizin AZU
15.
Cetirizin Basics
16.
Cetirizine Dihydrochloride
17.
Cetirlan
18.
P-071
19.
Reactine
20.
Virlix
21.
Voltric
22.
Zetir
23.
Zirtek
24.
Zyrtec
25.
Dihydrochloride, Cetirizine
26.
P 071
27.
P071
External Link(s)
MeSHD017332
PubChem Compound2678
BindingDB22890
ChEBI3561
CHEMBLCHEMBL1000
DrugBankDB00341
DrugCentral581
IUPHAR/BPS Guide to PHARMACOLOGY1222
KEGGcpd:C07778
dr:D07662
Therapeutic Target DatabaseD0DK8V
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 88
Canada Vigilance: 49
Canada Vigilance
OFFSIDES
US FAERS
2PruritusFAERS: 57
Canada Vigilance: 11
9934406
11034010
CTD
SIDER
Canada Vigilance
US FAERS
3UrticariaFAERS: 49
Canada Vigilance: 16

View details

CTD
SIDER
Canada Vigilance
US FAERS
4Product quality issueFAERS: 47US FAERS
5SomnolenceFAERS: 41
Canada Vigilance: 93
Canada Vigilance
SIDER
US FAERS
6Extra dose administeredFAERS: 33US FAERS
7FatigueFAERS: 30
Canada Vigilance: 31
Canada Vigilance
OFFSIDES
SIDER
US FAERS
8No adverse eventFAERS: 26US FAERS
9AnxietyFAERS: 23
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
10Drug DependenceFAERS: 21US FAERS
11Drug withdrawal syndromeFAERS: 21US FAERS
12Sudden infant death syndromeFAERS: 21US FAERS
13HeadacheFAERS: 19
Canada Vigilance: 43
Canada Vigilance
SIDER
US FAERS
14VertigoFAERS: 18
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
15SoporFAERS: 17US FAERS
16Expired product administeredFAERS: 14US FAERS
17MalaiseFAERS: 14
Canada Vigilance: 14
Canada Vigilance
SIDER
US FAERS
18Medication ErrorFAERS: 14US FAERS
19NauseaFAERS: 14
Canada Vigilance: 28
Canada Vigilance
OFFSIDES
SIDER
US FAERS
20TachycardiaFAERS: 14
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
21Abdominal PainFAERS: 13
Canada Vigilance: 12
Canada Vigilance
SIDER
US FAERS
22HypersensitivityFAERS: 13
Canada Vigilance: 7
8891761CTD
SIDER
Canada Vigilance
US FAERS
23LethargyFAERS: 13
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
24Accidental overdoseFAERS: 12US FAERS
25DysuriaFAERS: 12SIDER
US FAERS
26TremorFAERS: 12
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
27AngerFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
28AngioedemaFAERS: 11SIDER
US FAERS
29Cardiac ArrestFAERS: 11US FAERS
30PalpitationsFAERS: 11
Canada Vigilance: 11
Canada Vigilance
SIDER
US FAERS
31ParanoiaFAERS: 11US FAERS
32VomitingFAERS: 11
Canada Vigilance: 10
Canada Vigilance
SIDER
US FAERS
33DizzinessFAERS: 10
Canada Vigilance: 39
Canada Vigilance
OFFSIDES
SIDER
US FAERS
34ErythemaFAERS: 10
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
US FAERS
35Eye irritationFAERS: 10US FAERS
36Feeling abnormalFAERS: 10
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
37AstheniaFAERS: 9
Canada Vigilance: 9
Canada Vigilance
OFFSIDES
SIDER
US FAERS
38jaundiceFAERS: 9SIDER
US FAERS
39OverdoseFAERS: 8US FAERS
40SyncopeFAERS: 8SIDER
US FAERS
41Feelings of worthlessnessFAERS: 7US FAERS
42Muscle tightnessFAERS: 7OFFSIDES
US FAERS
43Product substitution issueFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
44Product use issueFAERS: 7US FAERS
45Urinary RetentionFAERS: 7SIDER
US FAERS
46Ventricular FibrillationFAERS: 7US FAERS
47nervous system disorderFAERS: 7SIDER
US FAERS
48Depressed moodFAERS: 6US FAERS
49DisorientationFAERS: 6
Canada Vigilance: 3
Canada Vigilance
US FAERS
50DystoniaFAERS: 616401869
18797375
CTD
US FAERS
51HypersomniaFAERS: 6US FAERS
52Long QT SyndromeFAERS: 6US FAERS
53Product use in unapproved indicationFAERS: 6US FAERS
54ThirstFAERS: 6SIDER
US FAERS
55Urinary tract infectionFAERS: 6SIDER
US FAERS
56Accidental exposure to product by childFAERS: 5US FAERS
57Blood creatinine increasedFAERS: 5US FAERS
58Blood glucose increasedFAERS: 5US FAERS
59CholestasisFAERS: 5SIDER
US FAERS
60Increased tendency to bruiseFAERS: 5US FAERS
61Intentional product misuseFAERS: 5US FAERS
62Joint swellingFAERS: 5US FAERS
63NocturiaFAERS: 5US FAERS
64PainFAERS: 5
Canada Vigilance: 7
Canada Vigilance
OFFSIDES
SIDER
US FAERS
65ThrombocytopeniaFAERS: 517955500CTD
SIDER
US FAERS
66Violence-related symptomFAERS: 5US FAERS
67AgitationFAERS: 4
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
68Anaphylactic shockFAERS: 4SIDER
US FAERS
69ArthralgiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
70Drug dispensing errorFAERS: 4US FAERS
71EpilepsyFAERS: 4US FAERS
72Expired drug administeredFAERS: 4US FAERS
73HepatitisFAERS: 4OFFSIDES
SIDER
US FAERS
74Incorrect dose administeredFAERS: 4OFFSIDES
US FAERS
75Mood swingsFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
76Product administration errorFAERS: 4US FAERS
77Product comminglingFAERS: 4US FAERS
78Abdominal discomfortFAERS: 3
Canada Vigilance: 9
Canada Vigilance
US FAERS
79ApathyFAERS: 3US FAERS
80BradycardiaFAERS: 3US FAERS
81Cholestatic liver injuryFAERS: 3US FAERS
82ConstipationFAERS: 3
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
83CryingFAERS: 3OFFSIDES
US FAERS
84Deficiency of bile secretionFAERS: 3US FAERS
85DiplopiaFAERS: 3US FAERS
86DroolingFAERS: 3US FAERS
87Drug dose omissionFAERS: 3US FAERS
88DysarthriaFAERS: 3US FAERS
89DysgeusiaFAERS: 3
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
90Emotional distressFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
91Erythema MultiformeFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
92Fixed eruptionFAERS: 3US FAERS
93Hepatic necrosisFAERS: 3US FAERS
94HepatotoxicityFAERS: 3US FAERS
95Impaired reasoningFAERS: 3US FAERS
96Live BirthFAERS: 3US FAERS
97Mixed liver injuryFAERS: 3US FAERS
98Musculoskeletal stiffnessFAERS: 3OFFSIDES
US FAERS
99Myasthenia GravisFAERS: 3US FAERS
100Product formulation issueFAERS: 3US FAERS
101Rash erythematousFAERS: 3SIDER
US FAERS
102Reaction to excipientFAERS: 3US FAERS
103Rebound effectFAERS: 3US FAERS
104RhinitisFAERS: 3
Canada Vigilance: 6
12167471
19672097
CTD
SIDER
Canada Vigilance
US FAERS
105SneezingFAERS: 3
Canada Vigilance: 4
8100058
9934406
CTD
Canada Vigilance
US FAERS
106SwellingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
107Therapy cessationFAERS: 3US FAERS
108Weight decreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
109Adverse eventFAERS: 2OFFSIDES
US FAERS
110AlopeciaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
111AmnesiaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
112AsthmaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
113AtaxiaFAERS: 215850951CTD
SIDER
US FAERS
114Autoantibody positiveFAERS: 2US FAERS
115Cerebral dysgenesisFAERS: 2US FAERS
116ChokingFAERS: 2US FAERS
117Cleft PalateFAERS: 2US FAERS
118Craniofacial deformityFAERS: 2US FAERS
119DehydrationFAERS: 2OFFSIDES
SIDER
US FAERS
120Delusional perceptionFAERS: 2US FAERS
121Depressed Level of ConsciousnessFAERS: 2US FAERS
122Drug abuseFAERS: 2US FAERS
123Drug dispensed to wrong patientFAERS: 2US FAERS
124Drug ineffective for unapproved indicationFAERS: 2US FAERS
125DyspepsiaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
126DysphoniaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
127Emotional disorderFAERS: 2US FAERS
128EnuresisFAERS: 2SIDER
US FAERS
129EpistaxisFAERS: 2
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
SIDER
US FAERS
130Facial ParesisFAERS: 2US FAERS
131Hallucinations, mixedFAERS: 2US FAERS
132Head discomfortFAERS: 2US FAERS
133HypotensionFAERS: 2SIDER
US FAERS
134Inappropriate schedule of drug administrationFAERS: 2US FAERS
135Incorrect drug administration durationFAERS: 2US FAERS
136Intentional self-injuryFAERS: 2US FAERS
137MaculeFAERS: 2US FAERS
138Maternal exposure during pregnancyFAERS: 2US FAERS
139MicropenisFAERS: 2US FAERS
140Oromandibular dystoniaFAERS: 2US FAERS
141Oropharyngeal painFAERS: 2
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
142PapuleFAERS: 2US FAERS
143PoisoningFAERS: 2US FAERS
144Poor quality sleepFAERS: 2OFFSIDES
US FAERS
145Product packaging issueFAERS: 2US FAERS
146Tension HeadacheFAERS: 2US FAERS
147Tonic clonic movementsFAERS: 2US FAERS
148Toxicity to various agentsFAERS: 2US FAERS
149Unresponsive to stimuliFAERS: 2US FAERS
150WheezingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
151Wrong technique in drug usage processFAERS: 2US FAERS
152Activities of daily living impairedFAERS: 1US FAERS
153Acute kidney injuryFAERS: 1US FAERS
154AgeusiaFAERS: 1SIDER
US FAERS
155Alanine Aminotransferase IncreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
156Alcohol interactionFAERS: 1US FAERS
157AnosmiaFAERS: 1US FAERS
158AphasiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
159AphoniaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
160Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
161Atrial FibrillationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
162Auricular swellingFAERS: 1US FAERS
163Band neutrophil count decreasedFAERS: 1US FAERS
164Bladder painFAERS: 1SIDER
US FAERS
165Blood cholesterol increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
166Blood triglycerides increasedFAERS: 1OFFSIDES
US FAERS
167Blood urea increasedFAERS: 1US FAERS
168BronchitisFAERS: 1OFFSIDES
SIDER
US FAERS
169BronchospasmFAERS: 1SIDER
US FAERS
170Burning sensationFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
171Cardiac FlutterFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
172Cerebral disorderFAERS: 1US FAERS
173Chest PainFAERS: 1
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
174Completed SuicideFAERS: 1SIDER
US FAERS
175Croup infectiousFAERS: 1US FAERS
176CystitisFAERS: 1SIDER
US FAERS
177DeafnessFAERS: 1SIDER
US FAERS
178DeliriumFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
179DiscomfortFAERS: 1SIDER
US FAERS
180Drug administration errorFAERS: 1US FAERS
181Drug exposure during pregnancyFAERS: 1US FAERS
182Drug prescribing errorFAERS: 1US FAERS
183Drug screen false positiveFAERS: 1US FAERS
184Excessive eye blinkingFAERS: 1US FAERS
185Exposure during breast feedingFAERS: 1US FAERS
186Feeling jitteryFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
187Food AllergyFAERS: 1US FAERS
188Foreign body sensation in eyesFAERS: 1US FAERS
189Gastric ulcerFAERS: 1US FAERS
190Guillain-Barre SyndromeFAERS: 1US FAERS
191HepatomegalyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
192HydronephrosisFAERS: 1US FAERS
193HypospadiasFAERS: 1US FAERS
194Idiopathic urticariaFAERS: 1US FAERS
195Immune thrombocytopenic purpuraFAERS: 1US FAERS
196Impaired work abilityFAERS: 1OFFSIDES
US FAERS
197Inappropriate affectFAERS: 1US FAERS
198Inappropriate schedule of product administrationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
199Incorrect product storageFAERS: 1US FAERS
200InfluenzaFAERS: 1US FAERS
201Infusion Site ExtravasationFAERS: 1US FAERS
202Intercepted drug dispensing errorFAERS: 1US FAERS
203Intrusive thoughtsFAERS: 1US FAERS
204Limb injuryFAERS: 1OFFSIDES
US FAERS
205Lymphocyte count increasedFAERS: 1US FAERS
206Mechanical urticariaFAERS: 1US FAERS
207Memory impairmentFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
208MenorrhagiaFAERS: 1SIDER
US FAERS
209Metabolic acidosisFAERS: 1US FAERS
210Monocyte count increasedFAERS: 1US FAERS
211Multiple SclerosisFAERS: 1US FAERS
212Multiple allergiesFAERS: 1OFFSIDES
US FAERS
213Nasal discomfortFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
214NasopharyngitisFAERS: 1SIDER
US FAERS
215Negative thoughtsFAERS: 1US FAERS
216Nephritis allergicFAERS: 1US FAERS
217NeutropeniaFAERS: 1US FAERS
218Obsessive thoughtsFAERS: 1US FAERS
219Optic NeuritisFAERS: 1US FAERS
220PharyngitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
221PresyncopeFAERS: 1US FAERS
222Product lot number issueFAERS: 1US FAERS
223Product package associated injuryFAERS: 1US FAERS
224Product packaging confusionFAERS: 1US FAERS
225Product physical issueFAERS: 1US FAERS
226Product taste abnormalFAERS: 1US FAERS
227Reaction to drug excipientsFAERS: 1US FAERS
228Respiratory arrestFAERS: 1US FAERS
229RestlessnessFAERS: 1US FAERS
230ScreamingFAERS: 1US FAERS
231ShockFAERS: 1SIDER
US FAERS
232SinusitisFAERS: 1OFFSIDES
SIDER
US FAERS
233SomnambulismFAERS: 1US FAERS
234StaringFAERS: 1US FAERS
235StillbirthFAERS: 1SIDER
US FAERS
236Suicide attemptFAERS: 1US FAERS
237TalipesFAERS: 1US FAERS
238Therapeutic response unexpectedFAERS: 1US FAERS
239Throat irritationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
240TinnitusFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
241Transcription medication errorFAERS: 1US FAERS
242Trisomy 21FAERS: 1OFFSIDES
US FAERS
243Urinary IncontinenceFAERS: 1SIDER
US FAERS
244Visual ImpairmentFAERS: 1SIDER
US FAERS
245Wrong drug administeredFAERS: 1OFFSIDES
US FAERS
246Abnormal clotting factorOFFSIDES
247Abnormal visionOFFSIDES
SIDER
248AbuseOFFSIDES
249Acid refluxOFFSIDES
250AcidosisOFFSIDES
251Acute Coronary SyndromeOFFSIDES
252Acute myocardial infarctionOFFSIDES
253Adjustment disorder with depressed moodCanada Vigilance: 1Canada Vigilance
254Aggressive reactionSIDER
255Altered state of consciousnessOFFSIDES
256Ammonia increasedOFFSIDES
257Anal FistulaOFFSIDES
258AnorexiaSIDER
259ApneaOFFSIDES
260Application site burnOFFSIDES
261Application site irritationOFFSIDES
262Application site pruritusOFFSIDES
263Application site rashOFFSIDES
264Application site reactionSIDER
265ArteriosclerosisOFFSIDES
266ArthritisSIDER
267ArthropathyOFFSIDES
SIDER
268AsterixisOFFSIDES
269Atherosclerosis25020133CTD
270Atrial FlutterOFFSIDES
271Atrial tachycardiaOFFSIDES
272Autoimmune hepatitisOFFSIDES
273BREAST PAIN FEMALESIDER
274Back PainCanada Vigilance: 2Canada Vigilance
SIDER
275Benign neoplasm of thyroid glandOFFSIDES
276Bladder discomfortCanada Vigilance: 1Canada Vigilance
277BlindnessSIDER
278Blood 1,25-dihydroxycholecalciferol decreasedOFFSIDES
279Blood GlucoseOFFSIDES
280Blood alkaline phosphatase increasedSIDER
281Blood and lymphatic system disordersSIDER
282Blood chloride decreasedOFFSIDES
283Blood cholesterolOFFSIDES
284Blood creatine phosphokinase increasedCanada Vigilance: 1Canada Vigilance
285Blood potassium increasedOFFSIDES
286Blood pressure inadequately controlledOFFSIDES
287Blurred visionOFFSIDES
288Bone painOFFSIDES
289BruxismOFFSIDES
290Bullous eruptionSIDER
291BursitisOFFSIDES
292CarcinomaOFFSIDES
293Cardiac enzymes increasedOFFSIDES
294Cardiac function test abnormalOFFSIDES
295Cardiac infectionOFFSIDES
296Carotid artery occlusionOFFSIDES
297Carotid bruitOFFSIDES
298CataractOFFSIDES
299CellulitisOFFSIDES
300Cerebral ThrombosisOFFSIDES
301Cerebral artery occlusionOFFSIDES
302Cervical myelopathyOFFSIDES
303Cervicobrachial syndromeOFFSIDES
304Chest discomfortCanada Vigilance: 6Canada Vigilance
305ChillsSIDER
306Chronic Obstructive Airway DiseaseOFFSIDES
307ChylothoraxOFFSIDES
308ClonusOFFSIDES
309Clostridium colitisOFFSIDES
310Clostridium difficile toxin test positiveOFFSIDES
311Cold sweatOFFSIDES
312Compression fractureOFFSIDES
313Congenital cystic kidney diseaseOFFSIDES
314Congenital pulmonary hypertensionOFFSIDES
315Conjunctival depositOFFSIDES
316ConjunctivitisCanada Vigilance: 7Canada Vigilance
SIDER
317Cramps of lower extremitiesSIDER
318Culture positiveOFFSIDES
319CystoceleOFFSIDES
320DemyelinationOFFSIDES
321Dental cariesSIDER
322DependenceOFFSIDES
323DermatitisSIDER
324DiabetesOFFSIDES
325Diabetes MellitusSIDER
326Diabetes mellitus inadequate controlOFFSIDES
327Disorders of Excessive Somnolence10868555CTD
328Disseminated Intravascular CoagulationOFFSIDES
329DissociationCanada Vigilance: 2Canada Vigilance
330Disturbance in sexual arousalSIDER
331Diverticular perforationOFFSIDES
332DiverticulitisOFFSIDES
333DiverticulosisOFFSIDES
334DiverticulumOFFSIDES
335DrowsinessOFFSIDES
336Drug Overdose15787309CTD
337Drug delivery system malfunctionOFFSIDES
338Drug withdrawal headacheOFFSIDES
339Dry skinOFFSIDES
SIDER
340Economic problemOFFSIDES
341EczemaOFFSIDES
SIDER
342Electrocardiogram ST segment abnormalOFFSIDES
343End stage AIDSOFFSIDES
344EndometriosisOFFSIDES
345Enlargement abdomenSIDER
346Enterococcal infectionOFFSIDES
347Enzyme abnormalityOFFSIDES
348Eosinophilia1355641
12689652
CTD
349Epileptic auraCanada Vigilance: 1Canada Vigilance
350Erectile dysfunctionCanada Vigilance: 2Canada Vigilance
OFFSIDES
351EructationSIDER
352Euphoric moodCanada Vigilance: 3Canada Vigilance
SIDER
353Eye painCanada Vigilance: 4Canada Vigilance
SIDER
354Facial PainCanada Vigilance: 1Canada Vigilance
355Failure to ThriveOFFSIDES
356Fatty Liver24852568CTD
357Feeling ColdCanada Vigilance: 1Canada Vigilance
358Feeling of body temperature changeCanada Vigilance: 1Canada Vigilance
359Fever15850951CTD
360FibromyalgiaOFFSIDES
361Fixed drug eruptionSIDER
362FlatulenceCanada Vigilance: 1Canada Vigilance
SIDER
363FlushingCanada Vigilance: 5Canada Vigilance
SIDER
364Food cravingOFFSIDES
365FormicationCanada Vigilance: 1Canada Vigilance
OFFSIDES
366FractureSIDER
367FurunculosisSIDER
368GamblingOFFSIDES
369Gamma-Glutamyltransferase IncreasedSIDER
370GangreneOFFSIDES
371GastritisSIDER
372Gastrointestinal PainSIDER
373Gastrointestinal obstructionOFFSIDES
374GlaucomaSIDER
375Global AmnesiaOFFSIDES
376GlomerulonephritisSIDER
377GranulocytosisOFFSIDES
378HemicephalalgiaOFFSIDES
379HemiparesisOFFSIDES
380Hip surgeryOFFSIDES
381HyperkeratosisSIDER
382HyperkinesiaSIDER
383Hypertensive heart diseaseOFFSIDES
384HyperthyroidismCanada Vigilance: 1Canada Vigilance
385HypertrichosisSIDER
386HyperventilationSIDER
387Hypoaesthesia facialOFFSIDES
388Hypocoagulable stateOFFSIDES
389HypogeusiaCanada Vigilance: 1Canada Vigilance
390HyporeflexiaOFFSIDES
391HypothyroidismCanada Vigilance: 1Canada Vigilance
392Impaired driving abilityOFFSIDES
393Increased bronchial secretionSIDER
394Increased viscosity of bronchial secretionCanada Vigilance: 1Canada Vigilance
395Infected cystOFFSIDES
396InfectionSIDER
397Infectious MononucleosisOFFSIDES
398Inhibitory drug interactionOFFSIDES
399Injection site inflammationSIDER
400Injection site papuleOFFSIDES
401Injury asphyxiationOFFSIDES
402Intention tremorOFFSIDES
403Intentional drug misuseOFFSIDES
404Intervertebral Disc DegenerationOFFSIDES
405Intra-aortic balloon placementOFFSIDES
406Intracranial AneurysmOFFSIDES
407Joint Range of Motion DecreasedOFFSIDES
408Joint stiffnessCanada Vigilance: 1Canada Vigilance
409Jugular vein distensionOFFSIDES
410Kidney FailureOFFSIDES
411Leg edemaSIDER
412LeukoencephalopathyOFFSIDES
413LeukoplakiaOFFSIDES
414LeukorrheaSIDER
415Limb discomfortCanada Vigilance: 2Canada Vigilance
416Lip swellingCanada Vigilance: 1Canada Vigilance
417LipaseOFFSIDES
418Lupus pneumonitisOFFSIDES
419LymphadenopathySIDER
420MalabsorptionOFFSIDES
421Malignant Carcinoid Syndrome18463367CTD
422MetrorrhagiaCanada Vigilance: 1Canada Vigilance
SIDER
423Mucosal erosionOFFSIDES
424Muscle RigidityCanada Vigilance: 1Canada Vigilance
425Muscle WeaknessOFFSIDES
426Musculoskeletal discomfortOFFSIDES
SIDER
427MyalgiaCanada Vigilance: 3Canada Vigilance
SIDER
428MyelitisSIDER
429MyoclonusSIDER
430Nasal PolypsSIDER
431Nephrogenic Fibrosing DermopathyOFFSIDES
432Nervous tensionOFFSIDES
433NervousnessCanada Vigilance: 1Canada Vigilance
SIDER
434NeurodermatitisOFFSIDES
435NoduleOFFSIDES
436Ocular Motility Disorders14962433
21190451
CTD
437OculogyrationSIDER
438Oculogyric crisisSIDER
439Open reduction of fractureOFFSIDES
440OrthopneaOFFSIDES
441OsteopeniaOFFSIDES
442OsteoporosisOFFSIDES
443Otitis MediaSIDER
444OtotoxicitySIDER
445PallorSIDER
446PancreatitisOFFSIDES
447Panic DisorderOFFSIDES
448Partner stressOFFSIDES
449Pelvic massOFFSIDES
450Pelvic prolapseOFFSIDES
451Pericarditis lupusOFFSIDES
452Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
453Pharyngolaryngeal PainOFFSIDES
454PhlebitisOFFSIDES
455PhonophobiaOFFSIDES
456Pityriasis RoseaCanada Vigilance: 1Canada Vigilance
457Platelet TransfusionOFFSIDES
458PlatybasiaOFFSIDES
459PneumoniaSIDER
460PolyuriaOFFSIDES
SIDER
461Postoperative ileusOFFSIDES
462Product complaintCanada Vigilance: 1Canada Vigilance
463Product label issueCanada Vigilance: 1Canada Vigilance
464PseudoporphyriaOFFSIDES
465PsoriasisOFFSIDES
466Pulmonary HypertensionOFFSIDES
467Pulmonary congestionOFFSIDES
468Pulmonary function test decreasedOFFSIDES
469PurpuraSIDER
470QuadriparesisOFFSIDES
471RectoceleOFFSIDES
472Renal cystOFFSIDES
473Renal tubular acidosisOFFSIDES
474Respiratory tract congestionOFFSIDES
475Respiratory tract irritationOFFSIDES
476Rhinitis, Allergic, Perennial9934406
11034010
20375960
CTD
477RhinorrheaOFFSIDES
478RhonchiOFFSIDES
479SclerodermaOFFSIDES
480ScotomaSIDER
481Seizures20012267CTD
482Selective MutismCanada Vigilance: 1Canada Vigilance
483Shoulder PainOFFSIDES
484Sick Sinus SyndromeOFFSIDES
485Sinus bradycardiaOFFSIDES
486Sinus headacheCanada Vigilance: 1Canada Vigilance
OFFSIDES
487Skeletal injuryOFFSIDES
488Skin ErosionOFFSIDES
489Skin IndurationOFFSIDES
490Skin lesionOFFSIDES
491Skin noduleSIDER
492Skin tightnessOFFSIDES
493Sleep Initiation and Maintenance Disorders20375960CTD
494Sleep TalkingOFFSIDES
495Spinal column stenosisOFFSIDES
496Spousal AbuseOFFSIDES
497Stasis dermatitisOFFSIDES
498StomatitisCanada Vigilance: 1Canada Vigilance
SIDER
499StressOFFSIDES
500StuporCanada Vigilance: 4Canada Vigilance
501Sudden Cardiac DeathOFFSIDES
502Sudden deathOFFSIDES
503SuicideSIDER
504SunburnCanada Vigilance: 1Canada Vigilance
505Suprapubic painOFFSIDES
506TendinitisOFFSIDES
507TensionSIDER
508Thoracic Outlet SyndromeOFFSIDES
509Tooth ExtractionOFFSIDES
510Tooth caries aggravated NOSSIDER
511Torsades de Pointes15787309CTD
512Transaminases increasedSIDER
513Transmission of an infectious agent via a medicinal productOFFSIDES
514Ulcerative stomatitisSIDER
515Urine output increasedSIDER
516Vaginal DischargeSIDER
517Vaginal ProlapseOFFSIDES
518Vascular purpuraSIDER
519Viral upper respiratory tract infectionOFFSIDES
520Visual disturbanceSIDER
521Vitamin B 12 DeficiencyOFFSIDES
522Vitamin K DeficiencyOFFSIDES
523Weight Gain24852568CTD
OFFSIDES
524XerophthalmiaSIDER
525effusionOFFSIDES
526furuncleSIDER
527muscle injuryOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.